Evolution, apoptosis, and autoimmune diseases

Pediatric Asthma, Allergy and Immunology

Volumn 11, Issue 1, 1997, Pages 9-16

  Shum, James C ^a,c   Frieri, Marianne ^b  

^a Lincoln Hospital   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CELL ORGANELLE; CHROMATID; EMBRYO DEVELOPMENT; EVOLUTION; FINGER; HUMAN; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS;

EID: 0030873615     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.1997.11.9     Document Type: Article

References (48)

1. Wyllie AH, Arenas MJ, Morris RG, Walker SW, Evan G. The apoptosis endonuclease and its regulation. Semin Immunol 1992; 4:389-97.
2. Savill S, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14:131-6.
3. Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32:223-54.
4. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68:251-306.
5. Duvall E, Wyllie AH. Death and the cell. Immunol Today 1986; 7:115-9.
6. Cagan RL, Ready DF. The emergence of order in Drosophila pupal retina. Dev Biol 1989; 136:346-62.
7. Wyllie AH. Cell Death in Biology and Pathology. C. Chapman and Hall: London, 1981, pp. 9-34.
8. Ruff MC. Social controls on cell survival and cell death. Nature (London) 1992; 356:398-400.
9. Yuan JY, Horvitz HR. The Caenorhabditis elegans genes ced-3 and ced-4 act on cells autonomously to cause programmed cell death. Dev Biol 1990; 138:33-41.
10. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The c. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993; 75:641-52.
11. Fleisher TA. Apoptosis. Ann Allergy Asthma Immunol 1997; 78:245-50.
12. McDonnell TJ, Deane N, Platt N, Nunez EM, Jaeger U, McKean JP. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular hypoproliferative cells. Cell 1989; 57:79-88.
13. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes hemopoietic cell survival and co-operation with c-myc to immortalize pre-B cells. Nature 1988; 335:440-2.
14. Vaux DL, Weissman IL, Kim SK. Prevention of program cell death in Caenorhabditis elegans by human bcl-2 gene. Science 1992; 258:1955-7.
15. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-65.
16. Herrmann JL, Brucheimer E, McDonnell TJ. Cell death signal transduction and Bcl-2 function. Biochem Soc Trans 1996; 24(4):1059-65.
17. Shi L, Walter K, Nishioka, Th'ng J, Bradbury EM, Litchfield DW, Greenberg AH. Prematured p34cdc2 activation required for apoptosis. Science 1994; 263:1143-5.
18. Rusel P, Nurse P. Negative regulation of mitosis by wee1 +, a gene encoding a protein kinase homolog. Cell 1987; 49:559-67.
19. Shiver JW, Su L, Henkart PA. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cell expressing both cytolysin and granzyme A. Cell 1992; 71:315-22.
20. Ryan JJ, Darish R, Gottlieb CA, Clarke MF. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 1993; 13:711-9.
21. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM. Interaction of the p53-regulated protein GADD45 with proliferation cell nuclear antigen. Science 1994; 266:1376-80.
22. Norimura T, Nomoto S, Katsuki M, Gondo Y, Kondo S. P53-dependant apoptosis suppresses radiation-induced teratogenesis. Nat Med 1996; 2(5):577-80.
23. Dive C, Hickman JA: Drug target interaction. Only the first step in the commitment to a programmed cell death? Br J Cancer 1991; 64:192-6.
24. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73:2013-26.
25. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley E, Fisher DE, Housman DE, Jack ST. p53 status and efficacy of cancer therapy in vivo. Science 1994; 266:807-10.
26. Willie AH. Glucocorticoid-induced thymocyte apoptosis associated with endogenous endonuclease activation. Nature (London) 1980; 284:555-6.
27. Nunez G, London L, Hockenbery D, Alexander M, McKean JP, Korsmeyer SJ. Deregulated Bcl-2 gene expression selectively prolonged survival of growth factor deprived hematopoietic cell lines. J Immunol 1990; 144:3602-10.
28. Caron-Leslie LM, Cidlowski JA. Similar action of glucocorticoids and calcium on the regulation of apoptosis in S49 cells. Mol Endocrinol 1991; 5:1169-79.
29. Caron-Leslie LM, Schwartzman RA, Gaido ML, Compton MM, Cidlowski JA. Identification and characterization of glucocorticoid-regulated nuclease(s) in lymphoid cells undergoing apoptosis. J Steroid Biochem Mol Biol 1991; 40:661-7.
30. Vaux DL. Towards an understanding of physiological cell death. Proc Natl Acad Sci USA 1993; 90:980-4.
31. Yonish-Rouah E, Grunwald P, Kimchi A, May E, Lawrence JJ, May P, Oren M. p53 mediated cell death: Relationship to cell cycle control. Mol Cell Biol 1993; 13:1415-23.
32. Debbas M, White E. Wild type p53 mediate apoptosis by E1A which is inhibited by E1B. Gene Dev 1993; 7:546-54.
33. Tsujimoto Y, Cosman J, Jaffs E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228:1440-3.
34. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267:1449-56.
35. Suda T, Takahushi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 1993; 1449-56.
36. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. Fas ligand in human serum. Nat Med 1996; 2:317-22.
37. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkina NA, Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 1992; 356:314-7.
38. Wu J, Zhou T, Zhang J, Croce M. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci USA, 1994; 91:2344-8.
39. Mountz JD, Zhou T, Wu J, Waang W, Su X, Cheng J. Regulation of apoptosis in immune cells. J Clin Immunol 1995; 15:1-16.
40. Fisher GH, Rosenberg FJ, Strause SE, Dale JK, Middleton LA, Lin AY, Strober M, Lenardom J, Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81:935-46.
41. Rieux-Laucat F, Le Diest C, Hivroz LAG, Roberts IA, Debatin KM, Fisher A, de Villartay JP. Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268:1347-9.
42. Drappa J, Valshnaw AK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 1996; 335:1643-9.
43. Sneller MC, Straus SE, Jaffe ES, Fleisher TA, Stetler-Stevenson M, Strober W. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 1992; 90:334-41.
44. Pisetsky DS. The immunologic properties of DNA. J Immunol 1996; 156:421-3.
45. Pisetsky DS. DNA and the immune system. Ann Intern Med 1997; 126(2):169-71.
46. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation-program cell death in neutrophil leads to its recognition by macrophages. Clin Invest 1989; 83:865-75.
47. Grigg J, Savill J, Sarraf C, Haslett C, Silverman M. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991; 338:7220-2.
48. Savill J, Smith J, Sarraf C, Ren Y, Abott F, Rees A. Glomberular mesangeal cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 1992; 42:924-936.